8P14
 
 | USP28 USP domain in complex with Vismodegib | Descriptor: | 2-chloranyl-~{N}-(4-chloranyl-3-pyridin-2-yl-phenyl)-4-methylsulfonyl-benzamide, CHLORIDE ION, Ubiquitin carboxyl-terminal hydrolase 28 | Authors: | Sauer, F, Karal Nair, R, Kisker, C. | Deposit date: | 2023-05-11 | Release date: | 2024-05-22 | Last modified: | 2024-12-04 | Method: | X-RAY DIFFRACTION (2.57 Å) | Cite: | Structural basis for the bi-specificity of USP25 and USP28 inhibitors. Embo Rep., 25, 2024
|
|
8P1Q
 
 | USP28 in complex with FT206 | Descriptor: | 3-azanyl-N-[(2S)-6-[(1S,5R)-3,8-diazabicyclo[3.2.1]octan-3-yl]-1,2,3,4-tetrahydronaphthalen-2-yl]-6-methyl-thieno[2,3-b]pyridine-2-carboxamide, DIMETHYL SULFOXIDE, Ubiquitin carboxyl-terminal hydrolase 28 | Authors: | Sauer, F, Karal Nair, R, Kisker, C. | Deposit date: | 2023-05-12 | Release date: | 2024-05-22 | Last modified: | 2024-12-04 | Method: | X-RAY DIFFRACTION (2.79 Å) | Cite: | Structural basis for the bi-specificity of USP25 and USP28 inhibitors. Embo Rep., 25, 2024
|
|
8P19
 
 | USP28 USP domain apo | Descriptor: | 1,2-ETHANEDIOL, CHLORIDE ION, Ubiquitin carboxyl-terminal hydrolase 28 | Authors: | Sauer, F, Karal Nair, R, Kisker, C. | Deposit date: | 2023-05-11 | Release date: | 2024-05-22 | Last modified: | 2024-12-04 | Method: | X-RAY DIFFRACTION (2.45 Å) | Cite: | Structural basis for the bi-specificity of USP25 and USP28 inhibitors. Embo Rep., 25, 2024
|
|
8P1P
 
 | USP28 in complex with AZ1 | Descriptor: | 2-[[5-bromanyl-2-[[4-fluoranyl-3-(trifluoromethyl)phenyl]methoxy]phenyl]methylamino]ethanol, CHLORIDE ION, DIMETHYL SULFOXIDE, ... | Authors: | Sauer, F, Karal-Nair, R, Kisker, C. | Deposit date: | 2023-05-12 | Release date: | 2024-05-22 | Last modified: | 2024-12-04 | Method: | X-RAY DIFFRACTION (2.76 Å) | Cite: | Structural basis for the bi-specificity of USP25 and USP28 inhibitors. Embo Rep., 25, 2024
|
|